Abstract
Attempts at using radiation for treating human malignancies began soon after the discovery of x-rays by Wilhelm Roentgen in 1895. Radiotherapy is a local treatment-modality in which ionizing radiation is delivered to areas either with gross tumor or with a high-risk of harboring microscopic disease. It is essentially noninvasive when delivered from an external source (teletherapy) or minimally invasive when using implanted radioactive sources (brachytherapy). Over the past century, advances in the understanding of the physics and biology of radiotherapy, as well as developments in imaging and radiation sources, have led to improved efficacy of radiation in controlling cancers while decreasing toxicity. Currently, radiotherapy plays a central role in the management of many genitourinary malignancies, for both definitive management of localized disease and palliation of metastatic disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fei P, El-Deiry WS. P53 and radiation responses. Oncogene. 2003;22(37):5774–83.
Corry J, Rischin D. Strategies to overcome accelerated repopulation and hypoxia–what have we learned from clinical trials? Semin Oncol. 2004;31(6):802–8.
Fowler JF. The radiobiology of prostate cancer including new aspects of fractionated radiotherapy. Acta Oncol. 2005;44(3):265–76.
Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys. 2003;56(4):1093–104.
Lichter AS, Lawrence TS. Recent advances in radiation oncology. N Engl J Med. 1995;332(6):371–9.
Litzenberg D, Dawson LA, Sandler H, et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 2002;52(3):699–703.
McGahan JP, Ryu J, Fogata M. Ultrasound probe pressure as a source of error in prostate localization for external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2004;60(3):788–93.
Bastasch MD, Teh BS, Mai WY, et al. Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer. Am J Clin Oncol. 2006;29(1):8–11.
Wei JT, Dunn RL, Sandler HM, et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20(2):557–66.
Crawford ED, Kozlowski JM, Debruyne FM, et al. The use of strontium 89 for palliation of pain from bone metastases associated with hormone-refractory prostate cancer. Urology. 1994;44(4):481–5.
Hartsell WF, Scott CB, Bruner DW, et al. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst. 2005;97(11):798–804.
Sartor O, Reid RH, Hoskin PJ, et al. Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer. Urology. 2004;63(5):940–5.
Parker C, Nilsson S, Helle SI, et al. Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med. 2013;369(3):213–23.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag London
About this chapter
Cite this chapter
Lee, I.H., Sandler, H.M. (2015). Principles of Radiotherapy in Urologic Tumors. In: Nargund, V., Raghavan, D., Sandler, H. (eds) Urological Oncology. Springer, London. https://doi.org/10.1007/978-0-85729-482-1_14
Download citation
DOI: https://doi.org/10.1007/978-0-85729-482-1_14
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-481-4
Online ISBN: 978-0-85729-482-1
eBook Packages: MedicineMedicine (R0)